PeDRA Pearls

Episode One: The Case for RIME

Dr. Erin Mathes discusses her clinical approach to RIME patients and highlights the reasons for keeping RIME as its own, independent condition.

The Drugs and Bugs Focused Study Group presents a spirited conversation on whether Reactive Infectious Mucocutaneous Eruption (RIME) should be a separate condition from Stevens-Johnson Syndrome (SJS). Moderated by Dr. Michele Ramien, Dr. Erin Mathes, and Dr. Yvonne Chiu debate RIME, SJS, and other blistering severe cutaneous adverse reactions.

Yakir Levin, MD, PhD is a Physician Scientist and Dermatologist at Massachusetts General Hospital, Instructor in Dermatology at Harvard Medical School, and an Investigator at the Wellman Center for Photomedicine. Watch to learn more about Dr. Levin’s interest in both medicine and electrical engineering and how he takes an interdisciplinary approach to bring the best possible care to his patients and their families.

PeDRA's Associate Director of Educational Programs had a chance to meet with several ISID attendees to get their take on the amazing science being presented at the inaugural International Societies for Investigative Dermatology meeting in Tokyo, Japan this last month. If you'd like to watch the video versions of these interviews, please click here.

Listen as PeDRA's Associate Director of Educational Programs, Jenn Dawson interviews several poster presenters at the ISID meeting in May 2023 in Tokyo, Japan. The interviews include a reference to an EB/Squamous Cell Carcinoma clinical trial. You can find more information about that trial here.

You can also view the on-camera interviews referenced in this episode here.

Cathryn Sibbald, MD, MSc is a dermatologist at the Hospital for Sick Children (SickKids) in Toronto, Canada. In addition to treating children, Dr. Sibbald also treats adults in community hospitals, providing her with the unique opportunity to continue caring for many patients that she treated as children. She is the co-chair of PeDRA’s Hair Disorders Focused Study Group and serves on both the PeDRA Grants and PeDRA Outcomes Committees. Listen now to learn more about Dr. Sibbald’s work, how she originally wanted to be a pharmacist before pursuing dermatology, and how she became a pet-parent during the pandemic.

Learn about maximizing relationships between attendings and trainees. Dawn Eichenfield, MD, PhD, Cheryl Bayart, MD, and A. Yasmine Kirkorian, MD along with their trainees share their wisdom in this round table discussion about creating a research relationship that’s mutually beneficial for both attendings and trainees.

This webinar offers presentations from Nanette Silverberg, MD, and Adelaide Hebert, MD to discuss the renewed interest in understanding the pathophysiology of molluscum and the importance of treatment versus a “watch and wait” strategy. Implications on patient quality of life and burden of illness are also discussed as well as managing difficult molluscum cases. Emerging therapeutic strategies are also reviewed.

This program is sponsored by Novan.

Click here to view the presentation slides.

Irene Lara-Corrales, MD is an associate professor of dermatology at the University of Toronto and a pediatric dermatologist at The Hospital for Sick Children (SickKids) in Toronto, Canada. She always knew she wanted to be a pediatric dermatologist, and her interest in epidermolysis bullosa (EB) grew deeper after treating a young baby with EB during her residency in Costa Rica. Most recently, she’s been championing Hidradenitis Suppurativa within PeDRA and the greater pediatric dermatology research community. Watch or listen to learn more about her passions, including her love of books and tea.

Maria Teresa García-Romero, MD, MPH is an attending physician and assistant professor at the National Institute of Pediatrics in Mexico. She currently serves on PeDRA’s Grants Committee and is a former member of the Early Investigator Committee. Her research interests include morphea, vascular anomalies, EB, and more. Listen to hear about her multi-country research collaborations and advice for international clinician scientists.

Listen to Dr. Harper Price and Dr. Lee Zane discuss Dr. Zane's unique experience in academic research as well as pharma. Dr. Zane shares his insights on everything from the keys to designing a good clinical trial to forming research questions that are valuable to achieving both clinical and industry regulatory goals.